Published in Aliment Pharmacol Ther on September 01, 2010
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Placebo effect in clinical trial design for irritable bowel syndrome. J Neurogastroenterol Motil (2014) 0.87
Irritable bowel syndrome: physicians' awareness and patients' experience. World J Gastroenterol (2012) 0.83
Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol (N Y) (2014) 0.82
Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol (2015) 0.79
Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol (2012) 0.79
Natural history of heartburn: a 10-year population-based study. World J Gastroenterol (2011) 0.78
From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries. Dig Dis Sci (2014) 0.77
Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: a Systematic Review and Meta-analysis. Gastroenterology (2017) 0.76
Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med (2014) 0.76
The tincture of time and irritable bowel syndrome symptoms. Gastroenterology (2011) 0.75
Diagnostic stringency and healthcare needs in patients with biliary dyskinesia. Dig Dis Sci (2013) 0.75
A simple method for assessing intestinal inflammation in Crohn's disease. Gut (2000) 2.69
Gastric response to metiamide. Br Med J (1974) 1.83
A study of Graves' disease in Iceland. Acta Med Scand (1975) 1.37
C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax (2005) 1.33
Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease. Gut (1977) 1.12
Trypsin and chymotrypsin in duodenal aspirate and faeces in response to secretin and cholecystokinin-pancreozymin. Gut (1974) 1.08
Gastric function in chronic renal failure. Effects of maintenance haemodialysis. Lancet (1975) 1.07
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther (1999) 1.07
Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut (2001) 1.05
Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man. Gut (1975) 1.03
Outcome of sub-total thyroidectomy for thyrotoxicosis in Iceland and Northeast Scotland. Clin Endocrinol (Oxf) (1977) 0.96
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease. Aliment Pharmacol Ther (2003) 0.95
Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology (Oxford) (1999) 0.95
Colonic varices. Report of an unusual case diagnosed by radionuclide scanning, with review of the literature. Gastroenterology (1986) 0.94
Response to pentagastrin in Man. IV. Dose-response characteristics. Acta Hepatogastroenterol (Stuttg) (1976) 0.93
Further studies of gastric hypersecretion in chronic renal failure. Br Med J (1974) 0.91
Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study. Aliment Pharmacol Ther (1999) 0.89
Effects of long-term treatment with metiamide. Digestion (1975) 0.87
Results of attempted cardiopulmonary resuscitation of patients dying suddenly outside the hospital in Reykjavik and the surrounding area, 1976-1979. Acta Med Scand (1982) 0.87
Uptake of L-carnitine by rat jejunal brush border microvillous membrane vesicles. Evidence of passive diffusion. Dig Dis Sci (1990) 0.86
Seroprevalence of Helicobacter pylori in south Sweden and Iceland. Scand J Gastroenterol (1996) 0.85
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group. Aliment Pharmacol Ther (1998) 0.84
Back-diffusion--fact or fiction? Digestion (1977) 0.84
Survey of prescriptions for peptic ulcer drugs (ACT class AOB2) in Iceland. Scand J Gastroenterol (1994) 0.83
Epidemiology of liver cirrhosis morbidity and mortality in Iceland. Eur J Gastroenterol Hepatol (1997) 0.83
Effect of metiamide on the response to secretin and cholecystokinin in man. Gut (1975) 0.82
Proceedings: Response to jejunal acidification in patients with duodenal ulcer and normal subjects. Gut (1975) 0.82
Thyroid function in normal subjects in Iceland and Northeast Scotland. Clin Endocrinol (Oxf) (1977) 0.82
Effect of metiamide on histamine metabolism in man. Digestion (1974) 0.81
Effects of metiamide on the human stomach. Clin Sci Mol Med (1975) 0.80
The effect of enteral carnitine administration in humans. Am J Clin Nutr (1992) 0.78
Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol (1991) 0.77
Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study. Scand J Gastroenterol (1993) 0.77
Aspects of basal gastric secretion in man. Digestion (1975) 0.77
Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0. Clin Exp Immunol (2005) 0.77
In vivo studies of intestinal carnitine absorption in rats. Gastroenterology (1985) 0.77
[The effect of coffee and tea upon lower esophageal sphincteric function.]. Laeknabladid (1995) 0.76
Effect of intraduodenal magnesium sulphate on pancreas and gallbladder of man. Gut (1976) 0.75
Iodine and the thyroid. Br Med J (1978) 0.75
[Drug administration and expenses for irritable bowel syndrome in Iceland.]. Laeknabladid (1996) 0.75
[The prevalence of H. pylori antibodies in Iceland.]. Laeknabladid (1996) 0.75
HeLa cell plasma membranes. IV. Iodination of membrane proteins in synchronized cells. Exp Cell Res (1978) 0.75
[Helicobacter pylori infection: the efficacy of a short course of azithromycin and fleroxacin treatment.]. Laeknabladid (1995) 0.75
[Trends in peptic ulcer morbidity and mortality in Iceland. Crowding, poor hygiene and the birth of high risk generations.]. Laeknabladid (1999) 0.75
Does sucralfate prevent short-term NSAID induced damage to the gastroduodenal mucosa? Digestion (1994) 0.75
Studies of carnitine metabolism in relation to intestinal absorption. Am J Physiol (1985) 0.75
[Endoscopic retrograde cholangio- pancreatography. An overview of procedures at the Natinal University Hospital in Reykjavik 1983-1992.]. Laeknabladid (1997) 0.75
Response to jejunal acidification in man. I. Changes in composition of perfusate. Scand J Gastroenterol (1976) 0.75
[A nationwide epidemiological study on celiac disease - the Icelandic picture.]. Laeknabladid (1995) 0.75
[A giant epiphrenic esophageal diverticulum in a patient with history of Zenker's diverticulum.]. Laeknabladid (1995) 0.75
[Helicobacter pylori infection: The efficacy of bismuth-tetracyclin-metronidazole triple therapy in patients with duodenal ulcer.]. Laeknabladid (1995) 0.75
Post-thyroidectomy thyrotoxicosis. Lancet (1978) 0.75
Response to pentagastrin in man. III. Comparison of two formulations. Acta Hepatogastroenterol (Stuttg) (1975) 0.75
Endoscopic findings in the stomach and duodenum after treatment with enteric-coated and plain naproxen tablets in healthy subjects. Scand J Gastroenterol (1990) 0.75
Response to jejunal acidification in man. II. Pancreatic, biliary and gastric responses. Scand J Gastroenterol (1976) 0.75
[Epidemiology of liver cirrhosis morbitity and mortality in Iceland.]. Laeknabladid (1996) 0.75
[Irritable bowel syndrome. Epidemiological study on young people in Iceland.]. Laeknabladid (1995) 0.75
[Herpes simplex esophagitis in immunocompetent individuals.]. Laeknabladid (1999) 0.75
[Comparison of the efficacy of Losec/Lómex and Zantac/Famex by continuous 24 hour gastric pH-metry.]. Laeknabladid (1997) 0.75
Enflurane hepatitis. A report of a case with a previous history of halothane hepatitis. Acta Anaesthesiol Scand (1985) 0.75